Intellia Therapeutics, Inc.

Amova Asset Management Americas, Inc. NTLA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

2,192,461

Value ($000)

19,688

Weight

0.2%

2019 Q4 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	19,688	0.2%	2,192,461	12/31/2025
2025 Q3	11/12/2025	40,621	0.4%	2,354,856	9/30/2025
2025 Q2	8/11/2025	25,003	0.2%	2,671,265	6/30/2025
2025 Q1	5/7/2025	20,004	0.3%	2,825,361	3/31/2025
2024 Q4	2/10/2025	34,894	0.4%	2,992,663	12/31/2024
2024 Q3	11/7/2024	64,668	0.7%	3,148,397	9/30/2024
2024 Q2	8/9/2024	72,907	0.8%	3,257,689	6/30/2024
2024 Q1	5/2/2024	93,379	0.9%	3,399,318	3/31/2024
2023 Q4	2/8/2024	105,957	1.0%	3,478,562	12/31/2023
2023 Q3	11/9/2023	111,171	1.3%	3,520,295	9/30/2023
2023 Q2	8/14/2023	138,298	1.5%	3,394,656	6/30/2023
2023 Q1	5/3/2023	111,444	1.3%	3,112,964	3/31/2023
2022 Q4	2/13/2023	103,743	1.5%	2,976,002	12/31/2022
2022 Q2	8/4/2022	141,143	1.7%	2,781,136	6/30/2022
2022 Q1	5/6/2022	192,442	1.4%	2,872,269	3/31/2022
2021 Q4	2/8/2022	327,714	1.7%	2,753,903	12/31/2021
2021 Q3	11/9/2021	322,191	1.4%	2,399,933	9/30/2021
2021 Q2	8/9/2021	507,307	2.0%	3,063,449	6/30/2021
2021 Q1	5/3/2021	388,697	1.9%	4,843,270	3/31/2021
2020 Q4	2/11/2021	277,677	1.6%	5,104,362	12/31/2020
2020 Q3	11/2/2020	121,857	1.1%	6,062,516	9/30/2020
2020 Q2	8/7/2020	123,671	1.6%	6,183,547	6/30/2020
2020 Q1	4/30/2020	86,726	1.6%	7,091,263	3/31/2020
2019 Q4	2/6/2020	105,309	1.7%	7,178,520	12/31/2019